Search results for "INFECTIONS"

showing 10 items of 2671 documents

Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.

2013

Substantial improvements in the safety of blood and plasma products for the management of bleeding disorders have been achieved in recent decades. This has led some clinicians to believe that the infectious threat is over and that inhibitor formation is the foremost complication of hemophilia therapy. On the contrary, elimination of all microbes from blood is difficult, potentially impossible, and there are always threats from emerging pathogens. The risk of infection transmission is also increasing due to greater exposure to products, increasing prophylaxis and high-dose regimens for immune tolerance, and longevity of hemophilia patients. Current products can be considered "reasonably safe…

medicine.medical_specialtyLong term treatmentContext (language use)Hemophilia AInfectionsEmerging infectionsSAFERHumans; Blood Coagulation Disorders; Hemophilia A; Blood Transfusion; InfectionmedicineHumansBlood TransfusionIntensive care medicinePathogenTransmission (medicine)business.industryRisk of infectionTransfusion ReactionHematologyBlood Coagulation Disordersmedicine.diseaseSettore MED/07 - Microbiologia e Microbiologia ClinicaThrombosisSurgeryHemostasisPlasma productsBlood safetyCardiology and Cardiovascular MedicinebusinessInfectionSeminars in thrombosis and hemostasis
researchProduct

The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell trans…

2019

The effect of timing of community acquired respiratory virus (CARV) infection after allogeneic hematopoietic stem cell transplant (allo-HCT) is an as yet unsettled issue. We evaluate this issue by including all consecutive allo-HCT recipients with molecularly-documented CARV infection during the first year after transplant. The study cohort was drawn from a prospective longitudinal survey of CARV in allo-HCT recipient having respiratory symptoms conducted from December 2013 to December 2018 at two Spanish transplant centers. Respiratory viruses in upper and/or lower respiratory specimens were tested using multiplex PCR panel assays. The study cohort comprised 233 allo-HCT recipients with 37…

medicine.medical_specialtyMultivariate analysisEpidemiologymedicine.medical_treatmentHematopoietic stem cell transplantationArticle03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologymedicineHumansProspective StudiesRespiratory systemRespiratory Tract InfectionsTransplantationbusiness.industryHematopoietic Stem Cell TransplantationHematologyOdds ratioConfidence intervalStem-cell researchVirus Diseases030220 oncology & carcinogenesisCohortVirusesRespiratory virusbusiness030215 immunologyBone marrow transplantation
researchProduct

A Multivariate Age-Structured Stochastic Model with Immunization Strategies to Describe Bronchiolitis Dynamics

2021

Bronchiolitis has a high morbidity in children under 2 years old. Respiratory syncytial virus (RSV) is the most common pathogen causing the disease. At present, there is only a costly humanized monoclonal RSV-specific antibody to prevent RSV. However, different immunization strategies are being developed. Hence, evaluation and comparison of their impact is important for policymakers. The analysis of the disease with a Bayesian stochastic compartmental model provided an improved and more natural description of its dynamics. However, the consideration of different age groups is still needed, since disease transmission greatly varies with age. In this work, we propose a multivariate age-struct…

medicine.medical_specialtyMultivariate statisticsStochastic modellingstochastic Bayesian modelHealth Toxicology and Mutagenesisrespiratory syncytial virusBayesian probabilityDiseaseRespiratory Syncytial Virus InfectionsPoisson distributioninfectious diseasesArticle03 medical and health sciencessymbols.namesakemultivariate age-structured model0302 clinical medicine030225 pediatricsMedicineHumans030212 general & internal medicineIntensive care medicineChildAge structuredimmunization programsbusiness.industryPublic Health Environmental and Occupational HealthInfant NewbornRInfantBayes TheoremImmunization (finance)medicine.diseaseRespiratory Syncytial VirusesBronchiolitisChild PreschoolsymbolsMedicineImmunizationbronchiolitisbusinessInternational Journal of Environmental Research and Public Health
researchProduct

Epidemiology and management of foodborne nematodiasis in the European Union, systematic review 2000–2016

2018

Background: Foodborne nematodiasis are caused by the ingestion of food contaminated by helminths. In Europe, these diseases are present in all countries. Objectives: To review the available data on epidemiology and management of foodborne nematodiasis in the European Union, detect any trends and determine the possible causes of the observed changes. Methods: A review of available literature published between 2000 and 2016 was conducted. Results: Out of 1523 cases described in the literature, 1493 cases were autochthonous and 30 cases were imported. The detected parasites were Toxocara spp (34.7%), Ascaris lumbricoides (27.1%), Trichinella spp (21.9%), Anisakis spp (15.5%) and Angiostrongylu…

medicine.medical_specialtyNematodaFood HandlingReviewsMicrobiologyFood handlingFoodborne Diseases03 medical and health sciences0302 clinical medicineEnvironmental healthparasitic diseasesEpidemiologymedicineAnimalsHumansHelminthsmedia_common.cataloged_instance030212 general & internal medicineEuropean unionNematode Infectionsmedia_commondigestive oral and skin physiologyZoonosisPublic Health Environmental and Occupational HealthGeneral Medicinemedicine.diseaseEuropeInfectious DiseasesGeographyCommunicable Disease Control030211 gastroenterology & hepatologyParasitologyPathogens and Global Health
researchProduct

New diagnostic possibilities in systemic neonatal infections: metabolomics

2014

Systemic neonatal infection is a serious complication in preterm and term infants and is defined as a complex clinical syndrome caused by bacteria, fungi and virus. Sepsis remains among the leading causes of death in both developed and underdeveloped countries above all in the neonatal period. Earlier diagnosis may offer the ability to initiate treatment to prevent adverse outcomes. There have been many studies on various diagnostic haematological markers like acute phase reactants, C-reactive protein, procalcitonin, interleukins and presepsin. However, there is still no single test that satisfies the criteria as being the ideal marker for the early diagnosis of neonatal sepsis. In this reg…

medicine.medical_specialtyNeonatal infections; metabolomicsNeonatal sepsisbusiness.industryAcute-phase proteinInfant NewbornObstetrics and Gynecologymedicine.diseaseProcalcitoninSingle testSepsisNeonatal infectionMetabolomicsSettore MED/38 - Pediatria Generale E SpecialisticaSepsisPediatrics Perinatology and Child HealthmedicineHumansMetabolomicsbusinessIntensive care medicineComplicationNeonatal infectionBiomarkers
researchProduct

Jugular pacing lead extraction with laser sheath: a case report.

2010

Over the past 20 years, the number of patients with pacemakers (PM) or implantable cardioverter defibrillators has risen markedly; consequently, an increasing number of lead-removal procedures have become necessary. A 64-year-old woman presenting with an infected device pocket and positive bacterial cultures ( Staphylococcus aureus ) was admitted to our department for lead removal; in 1991, she underwent VVI PM implantation for atrioventricular II degree Mobitz 1 block, and a unipolar lead was introduced via the left jugular vein. The procedure was performed in our Electrophysiology Lab with a cardiac surgeon on standby, using an excimer laser system emitting the energy at the tip of a flex…

medicine.medical_specialtyPacemaker ArtificialProsthesis-Related Infectionslaw.inventionlawPhysiology (medical)Jugular veinlead extracion laser sheatMedicineHumansLead (electronics)Device RemovalEndocarditisbusiness.industryLasersCardiac Pacing ArtificialMiddle AgedStaphylococcal InfectionsLaserSettore MED/11 - Malattie Dell'Apparato CardiovascolareSurgeryCardiothoracic surgeryFluoroscopyFemaleJugular VeinsCardiology and Cardiovascular MedicinebusinessLead extractionEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
researchProduct

P343 Procalcitonin role in the management of lower respiratory tract infections in preschool children

2017

Introduction One of the major advantage of procalcitonin compared to other parameters is its highly and early increase in response to bacterial infection. The increased procalcitonin levels can be observed 3 to 6 hours after infectious challenge. It is a parameter that made a significant contribution to the clinical diagnosis, severity of infection and in the same time procalcitonin kinetics cand be used to assess the effectiveness of treatment. Methods A single- centre observational study consecutively enrolled 70 preschool children with lower respiratory tract infections who were hospitalised in Paediatric Clinic Hospital of Sibiu between January 2013 and January 2017. Procalcitonin, were…

medicine.medical_specialtyPaediatric clinicRespiratory tract infectionsmedicine.drug_classbusiness.industryAntibioticsBronchopneumoniamedicine.diseaseProcalcitoninClinical diagnosisInternal medicinemedicineObservational studybusinessIntensive care medicineHospital stayPosters
researchProduct

Epidemiology of pneumococcal disease in children in Germany

2001

UNLABELLED Recently published and as yet unpublished data allow a reasonable estimate of the annual burden of pneumococcal disease in Germany. At least 277,000 episodes of otitis media and at least 2,000 episodes of sinusitis occur in children under the age of 5 y. Pneumococcal meningitis was found in 200 children under the age of 16 y; the estimate for all age groups ranges from 450 to 1100 cases. Of approximately 150,000 cases of ambulatory pneumococcal pneumonia, at least 63,000-105,000 patients are hospitalized each year. CONCLUSION Further studies of pneumococcal epidemiology in Germany are needed, and continued surveillance will be necessary for a better understanding of the overall b…

medicine.medical_specialtyPediatricsAdolescentPrevalencemedicine.disease_causePneumococcal InfectionsGermanyEpidemiologyStreptococcus pneumoniaemedicineHumansSerotypingSinusitisChildMeningitis Pneumococcalbusiness.industryData CollectionIncidenceIncidence (epidemiology)Bacterial pneumoniaGeneral Medicinemedicine.diseaseHospitalizationOtitis MediaStreptococcus pneumoniaeOtitisPopulation SurveillancePediatrics Perinatology and Child HealthPneumococcal pneumoniaImmunologymedicine.symptombusinessMeningitisActa Paediatrica
researchProduct

The paradox of the evidence about invasive fungal infections prevention

2016

Invasive fungal infections (IFIs) are characterized by high morbidity and mortality in non-neutropenic critically ill patients. Attributable mortality due to Candida spp. infections ranges from about 42 to 63 % [1, 2]. Data from large observational and retrospective studies show an association between early antifungal treatment and improved survival [3, 4]. Updated clinical practice guidelines for the management of candidiasis have been recently published [5]. In 2006, Playford et al. published a Cochrane systematic review investigating the use of antifungal agents for prevention of IFIs in non-neutropenic critically ill patients [6]. In that review, the outcome of proven IFI was defined as…

medicine.medical_specialtyPediatricsAntifungal AgentsUrinary systemMEDLINECritical Care and Intensive Care Medicinelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineAntifungal AgentHumansInfection controlInvasive Fungal Infection030212 general & internal medicinebusiness.industryAntifungal Agents; Humans; Invasive Fungal Infections; Critical Care and Intensive Care Medicine030208 emergency & critical care medicineRetrospective cohort studyFungal EsophagitisEditorialmedicine.anatomical_structureObservational studybusinessInvasive Fungal InfectionsHumanRespiratory tractCritical Care
researchProduct

How to manage aspergillosis in non-neutropenic intensive care unit patients.

2014

Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level …

medicine.medical_specialtyPediatricsChronic ObstructiveAntifungal AgentsCritical IllnessPopulationPulmonary diseaseSettore MED/41 - AnestesiologiaReviewNeutropeniaOpportunistic InfectionsAspergillosisCritical Care and Intensive Care MedicineCommunicable DiseasesCommunicable Diseases Emerginglaw.inventionPulmonary DiseaseImmunocompromised HostPulmonary Disease Chronic ObstructiveAspergillosis non-neutropenic ICUlawAdrenal Cortex HormonesRisk FactorsEpidemiologymedicinenon-neutropenicPrevalenceAspergillosisHumansIntensive care medicineeducationEmergingeducation.field_of_studybusiness.industryIncidence (epidemiology)Medicine (all)IncidenceAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised Host; Critical Care and Intensive Care Medicinemedicine.diseasePrognosisIntensive care unitAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised HostIntensive Care UnitsCohortICUAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised Host; Critical Care and Intensive Care Medicine; Medicine (all)businesssepsis aspergillosis icu managementCritical care (London, England)
researchProduct